61 retractions for controversial psychologist Hans Eysenck? That’s a significant underestimate, says his biographer

Rod Buchanan

In a recent Retraction Watch guest post on the “Eysenck affair,” James Heathers notes the extraordinary possibility that as many as 61 Hans Eysenck publications might be retracted. I believe this figure is a significant underestimate.

This reckoning has been a long time coming. The issues surrounding Eysenck’s 1980s/1990s collaboration with Ronald Grossarth-Maticek and their unbelievable results linking personality to health outcomes have been known for decades. Many eminent researchers, including Tony Pelosi and Louis Appleby, had lined up to criticise this research even while it was still ongoing. 

In 2010, I published a lengthy biography of Eysenck, Playing with fire, that detailed the context for this collaboration. In the final full chapter, I explained what prompted Eysenck to team up with this outsider figure and laid bare the extent of Eysenck’s deep and longstanding relationship with the tobacco industry. It was backed by extensive archival research and interviews with key players (including two days with Grossarth-Maticek). I had hoped it would provoke a reappraisal and remedial action. But the impact was minimal.

Continue reading 61 retractions for controversial psychologist Hans Eysenck? That’s a significant underestimate, says his biographer

Former Northwestern psychology prof has paper subjected to an expression of concern

A paper by Ping Dong, a former researcher at Northwestern who left her post less than a year after having a paper retracted from Psychological Science, has been subjected to an expression of concern.

The 2017 paper, in the Journal of Consumer Research, claimed to show that “Witnessing Moral Violations Increases Conformity in Consumption.” It has been cited just twice, according to Clarivate Analytics’ Web of Knowledge.

The expression of concern reads:

Continue reading Former Northwestern psychology prof has paper subjected to an expression of concern

“I decline to respond” but “take this history to undermine”

via Flickr

There are various ways to respond to criticism of one’s work. There is the “well, that’s not pleasant news, but thank you, I’ll correct that straightaway” approach. There’s the “I guess we’ll correct this but hope no one notices” approach. There’s the “I’m suing you” approach — often followed by “never mind.”

And then there’s the approach taken by Barbara Fredrickson of the University of North Carolina at Chapel Hill.

Fredrickson is perhaps best known for her work on the “positivity ratio,” around which she has built a significant brand. The idea, in a nutshell, is that you’ll be more successful if you have three positive emotions for every negative one. It is a compelling and bite-sized idea, and has been turned into a book.

Continue reading “I decline to respond” but “take this history to undermine”

“Do we have the will to do anything about it?” James Heathers reflects on the Eysenck case

James Heathers

We have a tension about resolving inaccuracies in scientific documents when they’re past a certain age.

Specifically, what should we do with old papers that are shown to be not just wrong, which is a fate that will befall most of them, but seriously misleading, fatally flawed, or overwhelmingly likely to be fabricated, i.e. when they reach the (very high) threshold we set for retraction?

To my way of thinking, there are three components of this:

Continue reading “Do we have the will to do anything about it?” James Heathers reflects on the Eysenck case

University finds dozens of papers by late — and controversial — psychologist Hans Eysenck “unsafe”

Hans Eysenck

More than two dozen papers by a controversial psychologist who died in 1997 are “unsafe,” according to a recent report by his former employer obtained by Retraction Watch.

The research has been subject to question for decades, because the findings — including some that “bibliotherapy” could dramatically reduce the risk of dying from cancer — seemed unbelievable.

The report by King’s College London into the work of Hans Eysenck and Ronald Grossarth-Maticek notes that: 

Continue reading University finds dozens of papers by late — and controversial — psychologist Hans Eysenck “unsafe”

Health care group withdraws rheumatoid arthritis drug report

An influential group that studies the economic burden of medical care has temporarily removed from its website a draft report about the cost-effectiveness of drugs to treat rheumatoid arthritis amid questions about the modeling researchers used in their analysis.  

The group initially did little to explain the move, despite having issued a press release for the document last week, replacing the report’s page with a brief statement:

Continue reading Health care group withdraws rheumatoid arthritis drug report

‘The problem is that there is no IL-26 gene in the mouse’ — an exasperated letter leads to a retraction

via Flickr

A group of ophthalmology researchers in China got caught trying to pull the wool over the eyes of readers by falsely claiming to have used a therapy that doesn’t exist. 

As its title would indicate, the article, “Anti-angiogenic effect of Interleukin-26 in oxygen-induced retinopathy mice via inhibiting NFATc1-VEGF pathway,” by a team from Jinhua Municipal Central Hospital in Zhejiang, purported to show that IL-26 could prevent the growth of new blood vessels in mice with damaged retinas. 

Per the abstract of the paper, which appeared in Biochemical and Biophysical Research Communications (BBRC): 

Continue reading ‘The problem is that there is no IL-26 gene in the mouse’ — an exasperated letter leads to a retraction

Hepatitis expert up to five retractions and one expression of concern denies reusing images

Gulam Waris

A microbiology journal has issued an expression of concern over image reuse in a 2010 paper whose senior author has already racked up five retractions for duplicating figures. 

The article, “Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway,” appeared in the Journal of General Virology, a publication of the Microbiology Society. The last author of the paper is Gulam Waris, an expert in viral hepatitis who is on the faculty of the Rosalind Franklin University of Medicine and Science in North Chicago. The paper has been cited 75 times, according to Clarivate Analytics’ Web of Science. 

By our count, Waris — whose work has made several appearances in PubPeer — has lost at least five papers to retraction for image duplication and questionable data. 

Continue reading Hepatitis expert up to five retractions and one expression of concern denies reusing images

Paper used to support ban on Caster Semenya competing earns massive correction

Caster Semenya

The authors of a controversial paper on what constitutes “normal” hormone levels in men and women  — and, by implication, “male” and “female” athletes — are set to issue a massive correction of the work, Retraction Watch has learned. But an outside, albeit not disinterested, researcher who prompted the correction says the correction itself is amiss. 

The article, “Large divergence in testosterone concentrations between men and women: frame of reference for elite athletes in sex-specific competition in sports, a narrative review,” appeared earlier this year in Clinical Endocrinology, a Wiley title. The authors of the meta-analysis, led by Richard Clark, of the US Anti‐Doping Agency, argued that testosterone levels between the sexes do not overlap in the absence of chromosomal or genetic anomalies that blur the distinction between male and female. 

That finding was cited recently by an architect of the International Association of Athletics Federations’ decision to bar the South African trackstar, Caster Semenya, and other “hyperandrogenic” women (Semenya’s hormonal status has not been made public) whose hormonal constitution is arguably more male than female. 

Continue reading Paper used to support ban on Caster Semenya competing earns massive correction

Meta-meta-analysis meets with retraction for group that had faked peer review elsewhere

Pancreatic cancer (artist rendering)

Researchers in China have lost a 2015 meta-analysis on pancreatic cancer, one of several retractions for members of the group stemming from a variety of abuses including bogus authorship and fake peer review. 

The meta-analysis, “Correlation between serum levels of high mobility group box-1 protein and pancreatitis: a meta-analysis,” appeared in BioMed Research International, a Hindawi journal. The authors are affiliated with China Medical University in Shenyang and Shanghai Jiao Tong University.

Here’s the notice

Continue reading Meta-meta-analysis meets with retraction for group that had faked peer review elsewhere